lipid system News
-
CD Bioparticles Releases Prostaglandins to Support Drug Delivery Research
CD Bioparticles, a leading manufacturer and supplier of various drug delivery products and services, now introduces a series of prostaglandins products to support drug delivery related research. These new products offer comprehensive choices for researchers, such as Prostaglandin F2a (11beta epimer), Prostaglandin A1, Prostaglandin F1ß, Prostaglandin E2, and Prostaglandin E1-d9. CD ...
-
CD Bioparticles Expands Lipid System Portfolio by the Launch of Sphingolipids
CD Bioparticles, a leading manufacturer and supplier of various drug delivery products and services, has now expanded lipid system portfolio and launched a series of Sphingolipids products to support customers' scientific research. CD Bioparticles now offers more choices for researchers to choose from and use in lipid system applications, such as Ceramides, Sphingosines, Sphingomyelin, ...
-
Acuitas Therapeutics Founders Receive Governor General’s Innovation Award
The founders of Acuitas Therapeutics, Drs. Pieter Cullis, Michael Hope and Thomas Madden, have been named as Governor General’s Innovation Award recipients. This prestigious award is for their work in developing lipid nanoparticle (LNP) systems to deliver cancer drugs to tumours and to enable RNA- and DNA-based drugs to be used therapeutically. Among other achievements, their work has ...
-
Visit of His Majesty the King of the Belgians Philippe and Her Majesty the Queen of the Belgians Mathilde to Afrigen Biologics
HM King Philippe and HM Queen Mathilde, currently on a state visit to South Africa until March 27, visited the Afrigen Biologics facility in Cape Town to learn more about how two Belgian companies, Univercells and etherna, are supporting the development of the first African- developed mRNA COVID-19 vaccine. The King and The Queen are accompanied by five ministers of federal and regional ...
By eTheRNA
-
CD Formulation Offers Customized Synthesis to Meet the Demand for Lipid Excipients in Drug Discovery
As a New York-based CRO company, CD Formulation has keenly observed that the demand for tailored pharmaceutical excipients is on the rise, especially over the past decade, as each formulation project may need unique excipients. In response to such a market trend, the management of CD Formulation earlier this month announces to offer customized synthesis for lipid excipients, which are used in ...
-
Pfizer Enters into Agreement with Acuitas Therapeutics for Lipid Nanoparticle Delivery System for Use in mRNA Vaccines and Therapeutics
Expands Pfizer’s access to lipid nanoparticle (LNP) formulation technology, offering a strong strategic fit with Pfizer’s mRNA strategy Pfizer gains option to license Acuitas’ LNP technology for up to 10 targets for vaccine or therapeutic development Pfizer Inc. (NYSE: PFE) and Acuitas Therapeutics, a company focused on developing lipid nanoparticle (LNP) delivery systems ...
-
Bayer strengthens gene therapy portfolio with lipid nanoparticle technology from Acuitas Therapeutics
Clinically validated lipid nanoparticle (LNP) delivery technology will further strengthen Bayer’s gene therapy portfolio High potency ionizable lipid technology and LNP carriers allow for efficient, targeted, and transient delivery of gene editing RNA components to the liver Bayer AG is joining forces with Acuitas Therapeutics, Inc., a biotechnology company specializing in the ...
By Bayer AG
-
Ziphius Vaccines and University of Antwerp Announce Collaboration Agreement for Optimized Delivery of saRNA-based Vaccines & Therapeutics
Ziphius Vaccines (the “Company” or “Ziphius”), a biopharmaceutical company developing transformative self-amplifying RNA (saRNA) based medicinal products for vaccine and therapeutic applications, and University of Antwerp today announce that they have entered into a collaboration agreement to research and develop a dynamic lipid library for optimized delivery systems ...
-
CD Formulation Newly Launches Disintegrant Excipients for Pharmaceutical Preparation
Excipients play an indispensable role in the process of pharmaceutical preparation. Disintegrants are added to a formulation to promote the drug release. To make disintegrant excipients easily accessible for scientists and researchers, CD Formulation recently announced that it now provides a wide range of disintegrant excipients that are frequently used in pharmaceutical research. The ...
-
CD Formulation: A Supplier of Binder Excipients for Pharmaceutical Preparation
Excipients play a remarkable role in the process of drug formulation. Binder excipients are used to improve the disintegration, bulkiness, bioavailability and dissolution rate of the drug. To make binder excipients more accessible for researchers, CD Formulation recently announced a comprehensive range of binder excipients that can be used in pharmaceutical research. By definition, the function ...
-
Lipidomics Bioinformation Analysis Now Available by Creative Proteomics’s Lipidomics Platform
As a division of Creative Proteomics, Lipidomics is dedicated to providing cutting-edge mass spectrometry (MS)-based lipidomics services for biomedical research institutions, biotechnological and pharmaceutical companies. The company has recently announced the launch of a fully-developed lipidomics bioinformation analysis service to screen differential lipid molecules and analyze their pathways, ...
-
BIOMARK’s GLIOBLASTOMA Study Published in CANCERS Demonstrates Inhibiting SAT1 sensitized cancer cells towards radiation and chemotherapy
Vancouver, British Columbia – (October 27th, 2022) – BioMark Diagnostics Inc. (“BioMark”) (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF) an advanced stage liquid biopsy company with a focus on hard to detect and treat cancers is pleased to announce today the publication of a preclinical study demonstrating therapeutic capabilities of its SAT1 cancer marker in glioblastoma (GB) ...
-
Agilent Technologies and national university of singapore sign research collaboration agreement for lipidomics research
Agilent Technologies Inc. (NYSE: A) and the National University of Singapore (NUS) today announced an agreement to develop expertise and knowledge in the area of analytical lipidomics. The goal of the partnership is to develop workflow solutions that enable researchers to more accurately understand disease states. Under the terms of the agreement, Agilent's provision of sophisticated test and ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you